ORAGENICS INC (OGEN)

NYSE · Pharmaceutical Preparations · Inc. FL

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for ORAGENICS INC. Most notable: 2026-07-06: Filed 8-K disclosing material agreement, director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-12Telling FreddirectorS2100.94$197
2025-12-12Telling FreddirectorS2100.94$197
2025-06-18Odyssey Health, Inc.ten percent ownerS5,0444.26$21,487
2025-06-17Odyssey Health, Inc.ten percent ownerS2,0004.46$8,920
2025-06-16Odyssey Health, Inc.ten percent ownerS5,0004.45$22,250
2025-06-13Odyssey Health, Inc.ten percent ownerS5,0004.27$21,350
2024-12-11KOSKI ROBERT CdirectorC5,000——
2024-12-06DUNTON ALAN WdirectorS660.36$24
2024-12-06Telling FreddirectorS3,5970.36$1,295

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

ORAGENICS INC (OGEN): insider trades, federal contracts, lobbying | IP Files